Freedom of Information request on medicines that will be withdrawn from Northern Ireland after the grace period (FOI 21/1013)
Published 27 April 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-11-october-2021/freedom-of-information-request-on-medicines-that-will-be-withdrawn-from-northern-ireland-after-the-grace-period-foi-211013
13th October 2021
FOI 21/1013
Dear
Thank you for your email and we apologise in our delay in response.
Please note that this is enquiry is outside the remit of MHRA and would be best responded to by the Department of Health and Social Care.
They can be contacted at Contact the Department of Health and Social Care - contactus.dh.gov.uk (dhsc.gov.uk)
Kind regards,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency